Literature DB >> 1925632

Chemotherapy of advanced cancer of the colon and rectum.

H W Bruckner1, B T Motwani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1925632

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  9 in total

1.  Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7.

Authors:  Shujie Chen; Tingting Su; Ying Zhang; Allen Lee; Jiamin He; Qiwei Ge; Lan Wang; Jianmin Si; Wei Zhuo; Liangjing Wang
Journal:  Gut Microbes       Date:  2020-01-07

2.  Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.

Authors:  Wen-Dan Chen; Xin Zhang; Ya-Ping Zhang; Cong-Bo Yue; Yan-Lei Wang; Hong-Wei Pan; Yan-Li Zhang; Hui Liu; Yi Zhang
Journal:  Curr Med Sci       Date:  2022-06-08

Review 3.  Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives.

Authors:  Julian Holch; Sebastian Stintzing; Volker Heinemann
Journal:  Visc Med       Date:  2016-06-07

4.  The therapeutic use of the unconjugated monoclonal antibodies (MAb) 17-1A in combination with GM-CSF in the treatment of colorectal carcinoma (CRC).

Authors:  P Ragnhammar; I Magnusson; G Masucci; H Mellstedt
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

5.  Acute phase proteins and recombinant IL-2 therapy: prediction of response and survival in patients with colorectal cancer.

Authors:  W G Simpson; S D Heys; P H Whiting; O Eremin; J Broom
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

6.  A clinical and pharmacological study of 5-fluorouracil, leucovorin and interferon alfa in advanced colorectal cancer.

Authors:  M J Moore; L Kaizer; C Erlichman; R Myers; R Feld; J J Thiessen; S Fine
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

7.  On Complex Formation between 5-Fluorouracil and β-Cyclodextrin in Solution and in the Solid State: IR Markers and Detection of Short-Lived Complexes by Diffusion NMR.

Authors:  Daria L Melnikova; Zilya F Badrieva; Mikhail A Kostin; Corina Maller; Monika Stas; Aneta Buczek; Malgorzata A Broda; Teobald Kupka; Anne-Marie Kelterer; Peter M Tolstoy; Vladimir D Skirda
Journal:  Molecules       Date:  2020-12-03       Impact factor: 4.411

8.  Bioavailability and feasibility of subcutaneous 5-fluorouracil.

Authors:  M M Borner; J Kneer; C Crevoisier; K W Brunner; T Cerny
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

9.  Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study.

Authors:  C N Sternberg; W W ten Bokkel Huinink; J F Smyth; V Bruntsch; L Y Dirix; N A Pavlidis; H Franklin; S Wanders; N Le Bail; S B Kaye
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.